Completed
Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration
NCT00460408
- Conditions
- Eye Diseases, Macular Degeneration, Retinal Degeneration, +1 more
- Locations
-
- Pfizer Investigational Site Brussels, Belgium
- Pfizer Investigational Site Charleroi, Belgium
- Pfizer Investigational Site Ieper, Belgium
- Pfizer Investigational Site Lier, Belgium